Congo Receives Over 16,000 Ebola Vaccine Doses Amid Record Outbreak

The Democratic Republic of Congo has taken delivery of more than 16,000 doses of the Ervebo vaccine in its fight against an unprecedented Ebola epidemic, according to the nation’s health minister. The shipment of 16,250 vaccine doses arrived at N’djili International Airport in Kinshasa on Friday night, representing the initial portion of a planned 70,000-dose allocation announced by the World Health Organization and partner organizations on Thursday. Additional doses are slated to arrive in the coming week.

The ongoing outbreak in Congo stems from the Bundibugyo virus variant, a strain for which no established treatment or licensed vaccine currently exists. The Ervebo vaccine, officially approved for Ebola treatment and proven successful in previous epidemics, may offer some cross-protection against Bundibugyo, according to WHO assessments. The virus presents particular containment challenges because its clinical presentation overlaps with common regional illnesses including malaria, complicating early detection and response.

As of Friday, the epidemic had claimed 2,516 lives among 5,290 confirmed cases, establishing it as the fastest-spreading Ebola outbreak in documented history. The outbreak is projected to eclipse the deadliest recorded incident, which killed more than 11,000 across West Africa from 2014 to 2016. The Africa Centre for Disease Control warns that transmission has not yet crested and could potentially triple from current transmission levels.

Multiple factors have impeded containment efforts, including ongoing armed conflict between government forces and rebel militias controlling outbreak epicenters, targeted violence against healthcare workers and medical infrastructure, significant labor migration patterns, mass displacement from combat zones, and deficient public health infrastructure throughout affected regions.